Background::Cholangiocarcinoma (CCA) is a malignant biliary tract tumor with an extremely poor prognosis. There is an urgent demand to explore novel therapeutic strategies. L-fucose has been confirmed to participate in anti-inflammation and antitumor activities. However, the effect of L-fucose on the progression of CCA has not been well investigated. This study aimed to determine whether L-fucose induced the inhibition of CCA and its possible mechanism.Methods::The anti-growth activity was determined using Cell Counting Kit-8 assay, colony formation assays, Annexin V-fluorescein isothiocyanate/propidium iodide (FITC/PI) assay, and cell cycle analysis. The anti-metastasis activity was determined by wound healing, transwell, and invasion assays. The anti-angiogenesis activity was determined by tube formation and transwell assays. MicroRNAs that may be involved in the L-fucose-induced CCA inhibition was analyzed using bioinformatics methods. The preclinical therapeutic efficacy was mainly estimated by ultrasound in xenograft nude mouse models. Differences were analyzed via Student’s t test or one-way analysis of variance. Results::L-Fucose induced apoptosis and G0/G1 cell cycle arrest, inhibited cell epithelial-mesenchymal transition of CCA cells, and additionally inhibited tube formation of human umbilical vein endothelial cells (HUVECs) in a dose-dependent manner, leading to a decrease in cell proliferation, metastasis, and angiogenesis. Mechanistically, L-fucose induced microRNA-200b (miR-200b) upregulation, and mitogen-activated protein kinase 7 (MAPK7) downregulation was found to be targeted by miR-200b, with decreased cell proliferation and metastasis. Additionally, phosphorylated signal transducer and activator of transcription 3 was found to be downregulated after L-fucose treatment. Finally, in vivo experiments in CCA xenograft models also confirmed the antitumor properties of L-fucose. Conclusion::L-Fucose inhibited the progression of CCA via the miR-200b/MAPK7 and signal transducer and activator of transcription 3 signaling pathways.

Cholangiocarcinoma;L-Fucose;MicroRNA-200b;Mitogen-activated protein kinase 7;Phosphorylated signal transducer and activator of transcription 3

Zhu Biqiang;Zheng Jingjing;Hong Gaichao;Bai Tao;Qian Wei;Liu Jinsong;Hou Xiaohua

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China;Department of Diagnostic Medical Sonography, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, China

中华医学杂志（英文版）

[1]Zhu Biqiang;Zheng Jingjing;Hong Gaichao;Bai Tao;Qian Wei;Liu Jinsong;Hou Xiaohua-.L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression)[J].中华医学杂志（英文版）,2022(24):2956-2967

Fucose,MAPK7

inhibits,progression,cholangiocarcinoma,by,causing,microRNA,200b,overexpression,Background,Cholangiocarcinoma,CCA,malignant,biliary,tract,extremely,poor,prognosis,There,urgent,demand,explore,novel,therapeutic,strategies,fucose,has,been,confirmed,participate,inflammation,antitumor,activities,However,effect,not,investigated,This,study,aimed,whether,induced,inhibition,possible,mechanism,Methods,growth,activity,was,determined,Cell,Counting,Kit,colony,formation,assays,Annexin,fluorescein,isothiocyanate,propidium,iodide,FITC,cycle,analysis,metastasis,wound,healing,transwell,invasion,angiogenesis,tube,MicroRNAs,that,may,involved,analyzed,bioinformatics,methods,preclinical,efficacy,mainly,estimated,ultrasound,xenograft,nude,mouse,models,Differences,were,via,Student,test,one,variance,Results,apoptosis,G0,G1,arrest,inhibited,epithelial,mesenchymal,transition,cells,additionally,human,umbilical,vein,endothelial,HUVECs,dose,dependent,manner,leading,proliferation,Mechanistically,miR,upregulation,mitogen,activated,protein,kinase,downregulation,found,targeted,decreased,Additionally,phosphorylated,transducer,activator,transcription,downregulated,after,treatment,Finally,vivo,experiments,also,properties,Conclusion,signaling,pathways,Mitogen,Phosphorylated

0.516684